Psyence Biomedical (PBM) Institutional Ownership $4.54 -0.10 (-2.16%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$4.64 +0.10 (+2.18%) As of 06/13/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Psyence Biomedical (NASDAQ:PBM)CurrentInstitutional OwnershipPercentage77.44%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$38.89MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.27M Get PBM Insider Trade Alerts Want to know when executives and insiders are buying or selling Psyence Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PBM Institutional Buying and Selling by Quarter Psyence Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 AdvisorShares Investments LLC26,923$57K0.0%-97.8%0.408% 2/14/2025 Harraden Circle Investments LLC182,323$385K0.3%N/A2.762% 2/11/2025 Virtu Financial LLC12,692$27K0.0%N/A0.192% 2/10/2025 Essential Planning LLC.73,278$163K0.0%N/A1.110% 8/8/2024 AdvisorShares Investments LLC463,042$148K0.0%+70.7%5.269% 5/20/2024 Virtu Financial LLC26,419$30K0.0%N/A0.301% (Data available from 1/1/2016 forward) PBM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBM shares? During the previous two years, the following institutional investors and hedge funds held shares of Psyence Biomedical shares: Harraden Circle Investments LLC ($385K), Essential Planning LLC. ($163K), and AdvisorShares Investments LLC ($57K), Virtu Financial LLC ($27K).Learn more on PBM's institutional investors. What percentage of Psyence Biomedical stock is owned by institutional investors? 77.44% of Psyence Biomedical stock is owned by institutional investors. Learn more on PBM's institutional investor holdings. Which institutional investors have been buying Psyence Biomedical stock? The following institutional investors have purchased Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($191.71K), Harraden Circle Investments LLC ($182.32K), Essential Planning LLC. ($73.28K), and Virtu Financial LLC ($39.11K). How much institutional buying is happening at Psyence Biomedical? Institutional investors have bought a total of 486,418 shares in the last 24 months. This purchase volume represents approximately $56.89M in transactions. Which Psyence Biomedical major shareholders have been selling company stock? The following institutional investors have sold Psyence Biomedical stock in the last 24 months: AdvisorShares Investments LLC ($1.21M). How much institutional selling is happening at Psyence Biomedical? Institutional investors have sold a total of 1,205,453 shares in the last 24 months. This volume of shares sold represents approximately $20.27M in transactions. Related Companies Trinity Biotech Major Shareholders BioCardia Major Shareholders Phio Pharmaceuticals Major Shareholders Eyenovia Major Shareholders Bright Green Major Shareholders GlycoMimetics Major Shareholders AEON Biopharma Major Shareholders Talphera Major Shareholders Citius Pharmaceuticals Major Shareholders Traws Pharma Major Shareholders This page (NASDAQ:PBM) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.